Published 3 June 2002. doi:10.1084/jem.20011887
© Rockefeller University Press, 0022-1007/2002/6/1479/ $5.00
The Journal of Experimental Medicine, Volume 195, Number 11, June 3, 2002 1479-1490
Inhibition of Methylcholanthrene-induced Carcinogenesis by an Interferon
Receptordependent Foreign Body Reaction
Zhihai Qin1,
Hye-Jung Kim2,
Jens Hemme2 and
Thomas Blankenstein1,2
1 Institute of Immunology, Free University, Berlin, 12200 Berlin, Germany
2 Max-Delbrück-Center for Molecular Medicine, 13092 Berlin, Germany
Address correspondence to Zhihai Qin, Institute of Immunology, Free University, Berlin 12200, Germany. Phone: 49-30-8445-4607; Fax: 49-30-8445-4613; E-mail: zhihai{at}ukbf.fu-berlin.de
The foreign body reaction is one of the oldest host defense mechanisms against tissue damage which involves inflammation, scarring, and encapsulation. The chemical carcinogen methylcholanthrene (MCA) induces fibrosarcoma and tissue damage in parallel at the injection site. Tumor development induced by MCA but not due to p53-deficiency is increased in interferon-
receptor (IFN-
R)deficient mice. In the absence of IFN-
R, MCA diffusion and DNA damage of surrounding cells is increased. Locally produced IFN-
induces the formation of a fibrotic capsule. Encapsulated MCA can persist virtually life-long in mice without inducing tumors. Together, the foreign body reaction against MCA prevents malignant transformation, probably by reducing DNA damage. This mechanism is more efficient in the presence of IFN-
R. Our results indicates that inflammation and scarring, both suspected to contribute to malignancy, prevent cancer in certain situations.
Key Words: inflammation tissue damage tissue repair encapsulation immune surveillance

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Elkabets, M., Krelin, Y., Dotan, S., Cerwenka, A., Porgador, A., Lichtenstein, R. G., White, M. R., Zoller, M., Iwakura, Y., Dinarello, C. A., Voronov, E., Apte, R. N.
(2009). Host-Derived Interleukin-1{alpha} Is Important in Determining the Immunogenicity of 3-Methylcholantrene Tumor Cells. J. Immunol.
182: 4874-4881
[Abstract]
[Full Text]
-
Xiao, M., Wang, C., Zhang, J., Li, Z., Zhao, X., Qin, Z.
(2009). IFN{gamma} Promotes Papilloma Development by Up-regulating Th17-Associated Inflammation. Cancer Res.
69: 2010-2017
[Abstract]
[Full Text]
-
Loser, K., Apelt, J., Voskort, M., Mohaupt, M., Balkow, S., Schwarz, T., Grabbe, S., Beissert, S.
(2007). IL-10 Controls Ultraviolet-Induced Carcinogenesis in Mice. J. Immunol.
179: 365-371
[Abstract]
[Full Text]
-
Simson, L., Ellyard, J. I., Dent, L. A., Matthaei, K. I., Rothenberg, M. E., Foster, P. S., Smyth, M. J., Parish, C. R.
(2007). Regulation of Carcinogenesis by IL-5 and CCL11: A Potential Role for Eosinophils in Tumor Immune Surveillance. J. Immunol.
178: 4222-4229
[Abstract]
[Full Text]
-
Willhauck, M. J., Mirancea, N., Vosseler, S., Pavesio, A., Boukamp, P., Mueller, M. M., Fusenig, N. E., Stark, H.-J.
(2007). Reversion of tumor phenotype in surface transplants of skin SCC cells by scaffold-induced stroma modulation. Carcinogenesis
28: 595-610
[Abstract]
[Full Text]
-
Krelin, Y., Voronov, E., Dotan, S., Elkabets, M., Reich, E., Fogel, M., Huszar, M., Iwakura, Y., Segal, S., Dinarello, C. A., Apte, R. N.
(2007). Interleukin-1{beta}-Driven Inflammation Promotes the Development and Invasiveness of Chemical Carcinogen-Induced Tumors. Cancer Res.
67: 1062-1071
[Abstract]
[Full Text]
-
Nishikawa, H., Kato, T., Tawara, I., Takemitsu, T., Saito, K., Wang, L., Ikarashi, Y., Wakasugi, H., Nakayama, T., Taniguchi, M., Kuribayashi, K., Old, L. J., Shiku, H.
(2005). Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts. Proc. Natl. Acad. Sci. USA
102: 9253-9257
[Abstract]
[Full Text]
-
Chatterji, U., Riby, J. E., Taniguchi, T., Bjeldanes, E. L., Bjeldanes, L. F., Firestone, G. L.
(2004). Indole-3-carbinol stimulates transcription of the interferon gamma receptor 1 gene and augments interferon responsiveness in human breast cancer cells. Carcinogenesis
25: 1119-1128
[Abstract]
[Full Text]
-
Enzler, T., Gillessen, S., Manis, J. P., Ferguson, D., Fleming, J., Alt, F. W., Mihm, M., Dranoff, G.
(2003). Deficiencies of GM-CSF and Interferon {gamma} Link Inflammation and Cancer. JEM
197: 1213-1219
[Abstract]
[Full Text]
-
Boon, T., van Baren, N.
(2003). Immunosurveillance against Cancer and Immunotherapy -- Synergy or Antagonism?. NEJM
348: 252-254
[Full Text]